That is exactly why i think once kevetrin shows proven efficacy, Leo moves fast to a buyout. We talk so much about kevetrin, and prurisol, but what about all the other compounds in development? KM391 for autism has shown some incredibly promising potnetial, and I am sure Dr Menon is anxious to put this compound in the drivers seat as soon as he can. Not to mention the other compounds in development, and the recent CDA signed regarding what many of us speculate is another great compound that may compliment kevetrin and address the difficulties that often comes with chemotherapy.

Lots to do, and for Dr Menon, i would bet time is the most important commodity. For this reason more than anything, i think from a scientific standpoint when kevetrin is proven, Leo and the good doc will send kevetrin to the major leagues, as by then the proper recognition, attention, and accolades will be given to all those involved. (And of course the financial tsunami that goes along with it)

It will be time to "move on" from Kevetrin, as the implications and impact of kevetrin on the open market will cement the legacy and historical significance of all those involved.

Truly we are fortunate to be a part of these exciting times in medical history. I feel humbled and fortunate to be able to say that i am a very small part of something that will hopefully bring hope and relief for so many.